- Home
- PSMT vs ACLX Comparison
PSMT vs ACLX Comparison
Compare PSMT & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSMT
- ACLX
- Stock Information
- Founded
- PSMT 1994
- ACLX 2015
- Country
- PSMT United States
- ACLX United States
- Employees
- PSMT N/A
- ACLX N/A
- Industry
- PSMT Department/Specialty Retail Stores
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- PSMT Consumer Discretionary
- ACLX Health Care
- Exchange
- PSMT Nasdaq
- ACLX Nasdaq
- Market Cap
- PSMT 2.8B
- ACLX 3.3B
- IPO Year
- PSMT 1997
- ACLX 2022
- Fundamental
- Price
- PSMT $104.45
- ACLX $57.55
- Analyst Decision
- PSMT
- ACLX Strong Buy
- Analyst Count
- PSMT 0
- ACLX 14
- Target Price
- PSMT N/A
- ACLX $109.33
- AVG Volume (30 Days)
- PSMT 240.0K
- ACLX 715.8K
- Earning Date
- PSMT 04-09-2025
- ACLX 05-08-2025
- Dividend Yield
- PSMT 1.21%
- ACLX N/A
- EPS Growth
- PSMT 18.49
- ACLX N/A
- EPS
- PSMT 4.69
- ACLX N/A
- Revenue
- PSMT $5,077,303,000.00
- ACLX $76,809,000.00
- Revenue This Year
- PSMT $9.02
- ACLX N/A
- Revenue Next Year
- PSMT $9.46
- ACLX $96.17
- P/E Ratio
- PSMT $22.56
- ACLX N/A
- Revenue Growth
- PSMT 8.65
- ACLX N/A
- 52 Week Low
- PSMT $77.51
- ACLX $47.88
- 52 Week High
- PSMT $102.82
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- PSMT 69.32
- ACLX 42.15
- Support Level
- PSMT $99.14
- ACLX $47.86
- Resistance Level
- PSMT $106.55
- ACLX $67.36
- Average True Range (ATR)
- PSMT 2.59
- ACLX 4.20
- MACD
- PSMT 0.35
- ACLX -0.70
- Stochastic Oscillator
- PSMT 83.27
- ACLX 49.69
About PSMT PriceSmart Inc.
Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.